Profil
Nancy Sacco is a former Head of Clinical Development at AnaptysBio, Inc. and a former Vice President and Head of Clinical Development at Xentria, Inc. She also served as the Chief Development Officer at Hexima Ltd.
in 2021-2022.
Sacco holds a doctorate degree from West Virginia University School of Medicine.
Anciens postes connus de Nancy Sacco
Sociétés | Poste | Fin |
---|---|---|
HEXIMA LIMITED | Corporate Officer/Principal | 15/10/2022 |
Xentria, Inc.
Xentria, Inc. BiotechnologyHealth Technology Xentria, Inc. is a biopharmaceutical company founded in 2020 that specializes in creating collaborations and partnerships to advance drug development. The company is based in Chicago, IL. The company is dedicated to delivering customized approaches to drug innovation through patient engagement and effective partnerships. Xentria is focused on becoming a critical leader in the biopharma industry through a strong portfolio of biologic products for patients. | Chief Tech/Sci/R&D Officer | - |
ANAPTYSBIO, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Nancy Sacco
West Virginia University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ANAPTYSBIO, INC. | Health Technology |
HEXIMA LIMITED | Health Technology |
Entreprise privées | 1 |
---|---|
Xentria, Inc.
Xentria, Inc. BiotechnologyHealth Technology Xentria, Inc. is a biopharmaceutical company founded in 2020 that specializes in creating collaborations and partnerships to advance drug development. The company is based in Chicago, IL. The company is dedicated to delivering customized approaches to drug innovation through patient engagement and effective partnerships. Xentria is focused on becoming a critical leader in the biopharma industry through a strong portfolio of biologic products for patients. | Health Technology |